Topelia Aust Pty Limited is an unlisted biotechnology company specializing in the development and commercialization of innovative antiviral therapies. The company's proprietary Antiviral Triple Therapy, including Ziverdox-T for COVID-19 treatment and Ziverdox-P as a prophylactic, aims to address urgent healthcare needs.